{
    "clinical_study": {
        "@rank": "68916", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "Patients randomized to Group 1 will receive PAN-90806 Ophthalmic Solution daily for the study duration."
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "Patients randomized to Group 2 will receive PAN-90806 Ophthalmic Solution daily for the study duration."
            }, 
            {
                "arm_group_label": "Group 3", 
                "arm_group_type": "Experimental", 
                "description": "Patients randomized to Group 3 will receive PAN-90806 Ophthalmic Solution daily for the study duration."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to assess the safety and tolerability of topical ocular\n      PAN-90806 in patients with active, subfoveal choroidal neovascularization associated with\n      neovascular Age-Related Macular Degeneration (AMD)."
        }, 
        "brief_title": "Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Age-Related Macular Degeneration (AMD)", 
        "condition_browse": {
            "mesh_term": [
                "Macular Degeneration", 
                "Wet Macular Degeneration"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis in the study eye of active, pathologic, newly diagnosed and previously\n             untreated, subfoveal choroidal neovascular (CNV) lesions secondary to neovascular AMD\n\n          -  Aged 50 years or older\n\n          -  Demonstrate the ability, or have a family member who is willing and able, to instill\n             topical ocular drops in the study eye\n\n        Exclusion Criteria:\n\n          -  No prior ocular or systemic treatment or surgery for neovascular AMD in the study eye\n\n          -  History of or current clinical evidence in the study eye of:\n\n               -  aphakia\n\n               -  diabetic macular edema\n\n               -  any ocular inflammation or infections\n\n               -  pathological myopia\n\n               -  retinal detachment\n\n               -  advanced glaucoma\n\n               -  significant media opacity, including cataract\n\n          -  History or evidence of the following surgeries in the study eye:\n\n               -  penetrating keratoplasty or vitrectomy;\n\n               -  corneal transplant;\n\n               -  corneal or intraocular surgery within 3 months of Screening\n\n          -  Uncontrolled hypertension despite use of antihypertensive medications\n\n          -  Participation in any investigational drug or device study, systemic or ocular, within\n             past 3 months\n\n          -  Women who are pregnant or nursing\n\n          -  Known serious allergies or hypersensitivity to the fluorescein dye used in\n             angiography or to the components of the PAN-90806 formulation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02022540", 
            "org_study_id": "PAN-01-101"
        }, 
        "intervention": {
            "arm_group_label": [
                "Group 1", 
                "Group 2", 
                "Group 3"
            ], 
            "intervention_name": "PAN-90806 Ophthalmic Solution", 
            "intervention_type": "Drug", 
            "other_name": "PAN-90806 Eye Drops"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Neovascular Age-Related Macular Degeneration", 
            "AMD", 
            "Macular Degeneration", 
            "Age-Related Macular Degeneration", 
            "wet AMD", 
            "neovascular AMD", 
            "exudative AMD"
        ], 
        "lastchanged_date": "June 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs", 
                        "country": "United States", 
                        "state": "Colorado"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winter Haven", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shawnee Mission", 
                        "country": "United States", 
                        "state": "Kansas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portsmouth", 
                        "country": "United States", 
                        "state": "New Hampshire"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bloomfield", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Statesville", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ashland", 
                        "country": "United States", 
                        "state": "Oregon"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Columbia", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rapid City", 
                        "country": "United States", 
                        "state": "South Dakota"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Abilene", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harlingen", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "McAllen", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Willow Park", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)", 
        "overall_contact": {
            "email": "kcurtiss@panopticapharma.com", 
            "last_name": "Kristine Curtiss", 
            "phone": "908-766-0899"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Presence of any targeted adverse events (TAEs); safety endpoints include adverse events, vital signs, laboratory abnormalities, ophthalmic findings and outcomes", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "2 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02022540"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "PanOptica, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PanOptica, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}